Business Context and Reporting Period
This Form 6-K filing by Quantum Biopharma Ltd. (formerly FSD Pharma Inc.) covers the month of August 2024, with the report dated August 15, 2024. The Company is a foreign private issuer headquartered in Toronto, Ontario, Canada.
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report serves as a notification of corporate actions rather than a financial results statement.
Material Changes
- Corporate Name Change: The Company has officially changed its name from FSD Pharma Inc. to Quantum Biopharma Ltd.
- Stock Consolidation: A 65:1 reverse stock split (consolidation) has been completed.
- Trading Symbol: The Company will trade under the new ticker symbol "QNTM".
Guidance, Outlook, and Risks
The filing does not contain management commentary on future guidance, outlook, specific risks, or contingencies. The document primarily incorporates by reference a press release detailing the name change and stock consolidation.
Investor Verification Checklist
- Verify the effective date of the 65:1 stock consolidation and its impact on existing shareholdings.
- Confirm the commencement of trading under the new ticker symbol "QNTM".
- Review the full text of the press release (Exhibit 99.1) for details on the rationale behind the name change and consolidation.
- Check subsequent filings for updated financial statements reflecting the post-consolidation capital structure.